Bingqian Zhou

发表

PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer

Rui Hu, Bingqian Zhou, Zheyi Chen, 2022, Frontiers in Immunology.

BACH2 regulates the function of human CD4+CD45RA−Foxp3l° cytokine‐secreting T cells and promotes B‐cell response in systemic lupus erythematosus

H. Nie, Bingqian Zhou, Zheyi Chen, 2019, European journal of immunology.

Therapy-induced mutations drive the genomic landscape of relapsed acute lymphoblastic leukemia.

Benjamin J. Raphael, Heather L. Mulder, Diane A. Flasch, 2019, Blood.

PRMT5 Deficiency Enforces the Transcriptional and Epigenetic Programs of Klrg1+CD8+ Terminal Effector T Cells and Promotes Cancer Development

Bingqian Zhou, Zheyi Chen, Shiyu Chen, 2021, The Journal of Immunology.

Immune suppressive landscape in the human esophageal squamous cell carcinoma microenvironment

Jian Cao, Rui Hu, Bingqian Zhou, 2020, Nature Communications.

Interleukin 32 Promotes Foxp3+ Treg Cell Development and CD8+ T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment

Bingqian Zhou, Zheyi Chen, Shiyu Chen, 2021, Frontiers in Cell and Developmental Biology.

PD-L1+CD8+ T cells enrichment in lung cancer exerted regulatory function and tumor-promoting tolerance

Xianting Ding, Rui Hu, Bingqian Zhou, 2022, iScience.

MST4 Regulates Epithelial–Mesenchymal Transition of Choriocarcinoma by Mediating TGF-β1 Expression

Bingqian Zhou, Beng Yang, Peilin Han, 2020, OncoTargets and therapy.

Prmt5 deficiency inhibits CD4+ T-cell Klf2/S1pr1 expression and ameliorates EAE disease

Bingqian Zhou, Zheyi Chen, Shiyu Chen, 2023, Journal of Neuroinflammation.

Prmt5 deficient mouse B cells display RNA processing complexity and slower colorectal tumor progression.

Bingqian Zhou, Zheyi Chen, Shiyu Chen, 2023, European Journal of Immunology.